BioCentury
ARTICLE | Financial News

Novo's REPAIR fund makes first investment in Swiss antibiotic company

September 7, 2018 6:07 PM UTC

Novo Holdings A/S invested CHF6.8 million ($7 million) on Sept. 6 into antibiotic company Polyphor Ltd. (SIX:POLN) through the purchase of 178,947 new shares at CHF38.

The funds come from Novo's REPAIR Impact Fund, which its early venture group Novo Seeds launched in February with $165 million to invest in biotechs developing therapies for antimicrobial resistance. Polyphor is the fund's first investment (see "Repairing Resistance")...

BCIQ Company Profiles

Novo Holdings A/S

Polyphor AG